Thursday, 5 October 2017

U.S. court reverses ban on sale of Sanofi, Regeneron drug Praluent

(Reuters) - A U.S. appeals court on Thursday threw out a ban on the sale of Sanofi SA and Regeneron Pharmaceuticals Inc's cholesterol-lowering drug Praluent.


No comments:

Post a Comment